Larson Financial Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.48K Sell
108
-15
-12% -$555 ﹤0.01% 2769
2025
Q4
$5.18K Buy
123
+26
+27% +$1.05K ﹤0.01% 2445
2025
Q3
$3.33K Buy
+97
New +$2.78K ﹤0.01% 2508
2023
Q4
Sell
-16
Closed -$357 1905
2023
Q3
$357 Buy
+16
New +$411 ﹤0.01% 1602

Other funds holding VCYT

Larson Financial Group's VCYT Position: Q1 2026 in Review

Larson Financial Group reduced its Veracyte (VCYT) stake by 12% in Q1 2026, selling an estimated $555 and leaving 108 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

Larson Financial Group first reported a position in VCYT in Q3 2023 and has held it in 4 quarters since. The position peaked at $5.18K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Larson Financial Group held 108 shares of Veracyte worth $3.48K as of Q1 2026.
  • Larson Financial Group sold 15 Veracyte shares in Q1 2026, an estimated $555.
  • Veracyte made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2769 holding.
  • Larson Financial Group first reported a position in Veracyte in Q3 2023 and has held it in 4 quarters since.
  • Larson Financial Group's Veracyte position peaked at $5.18K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.